Trial intelligence / Profile preview

Propofol anesthesia depth and postoperative cognitive dysfunction in older surgical patients

ChiCTR-TRC-14004312Phase 4Recruiting

Sponsor
Third Xiangya Hospital, Central South University
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol in post-operative cognitive decline (POCD) (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Incidence of postoperative cognitive dysfunction under different depths of anesthesia, Risk factors of postoperative cognitive dysfunction and 1 more. Started Mar 2014; status: recruiting.

02

Drugs

propofol
03

Conditions

post-operative cognitive decline (POCD)

Beyond the preview

Go deeper on ChiCTR-TRC-14004312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call